Cargando…
Neurological diagnoses in hospitalized COVID‐19 patients during the B.1.1.529 surge
OBJECTIVE: Emerging variants and sublineages of SARS‐CoV‐2 have differing disease severity, transmissibility, and immune evasion. The neurological conditions associated with the original strain of SARS‐CoV‐2 are well established. Our study assessed the neurological presentations specific to hospital...
Autores principales: | Kim, Carla Y., Sardar, Zomer, Ayele, Biniyam A., Fleck‐Derderian, Shannon, Barrett, Catherine E., Sun, Yifei, Clague, Madison, Hurst, Holly A., Boruah, Abhilasha, Zucker, Jason, Maddox, Ryan, Sejvar, James, Thakur, Kiran T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424653/ https://www.ncbi.nlm.nih.gov/pubmed/37350635 http://dx.doi.org/10.1002/acn3.51833 |
Ejemplares similares
-
Outcomes of Monoclonal Antibody Infusion Treatment During Delta (B.1.617.2) and Omicron (B.1.1.529) COVID 19 Variant Surges among Vaccinated and Unvaccinated Patients
por: Ghazanfar, Haider, et al.
Publicado: (2022) -
Clinical characteristics and outcomes of SARS-Cov-2 B.1.1.529 infections in hospitalized patients and multi-surge comparison in Louisiana
por: Taylor, Katie, et al.
Publicado: (2022) -
Effect of COVID-19 Delta (B.1.617.2) and Omicron (B.1.1.529) surges on emergency medicine physician compassion
por: Bowling, John M., et al.
Publicado: (2022) -
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
por: Andrews, Nick, et al.
Publicado: (2022) -
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021)